The gene expression signatures here support potential disease models of BRG1 contributing significantly to cancer progression in multiple avenues and also provide support for the observations that BRG1 is involved in highly aggressive forms of prostate and skin cancers (Saladi et al, 2010; Muthuswami et al, 2019). The gene discussed is SMARCA4; the disease is cancer.